Discontinued — last reported Q4 '25
MetLife Assumed Reinsurance — Other liabilities decreased by 8.7% to $1.70B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 8.7%, from $1.86B to $1.70B. This is a positive signal — lower values indicate better performance for this metric.
An increase may signal rising operational costs or tax obligations, while a decrease suggests improved expense management.
This represents non-policy-specific liabilities associated with the assumed reinsurance segment, such as accrued expense...
Comparable to general 'other liabilities' or 'accrued expenses' reported in segment disclosures.
met_segment_assumed_reinsurance_other_liabilities| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.14B | $2.01B | $1.89B | $1.86B | $1.70B |
| QoQ Change | — | -6.2% | -5.7% | -1.5% | -8.7% |
| YoY Change | — | -6.2% | -5.7% | -1.5% | -8.7% |